• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Kymera Therapeutics, Inc. - Common Stock (NQ:KYMR)

    83.85 -2.83 (-3.26%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Apr 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 459,225
    Open 86.89
    Bid (Size) 80.00 (100)
    Ask (Size) 86.77 (200)
    Prev. Close 86.68
    Today's Range 83.80 - 88.39
    52wk Range 28.06 - 103.00
    Shares Outstanding 55,307,775
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗
    Kymera Therapeutics develops targeted protein degradation therapies for immunology and oncology, advancing a diversified clinical pipeline. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗
    This clinical-stage biotech targets retinal diseases with late-stage drug candidates and a focused pipeline in ophthalmology. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +15.2%
    +15.2%
    1 Month
    +5.5%
    +5.5%
    3 Month
    +18.0%
    +18.0%
    6 Month
    +37.8%
    +37.8%
    1 Year
    +149.5%
    +149.5%

    More News

    Read More
    News headline image
    Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    Kymera Therapeutics Inc (NASDAQ:KYMR) Stock Falls 6.6% After Q4 2025 Earnings Miss and Extended Clinical Timelines ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Earnings Scheduled For November 4, 2025 ↗
    Via Benzinga
    News headline image
    Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kymera (KYMR) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Structure Therapeutics Stock Soars Over 200% as One Fund Adds to a $242 Million Position ↗
    Via The Motley Fool
    News headline image
    Protagonist Stock Up 120%, but One Fund Just Revealed a $170 Million Exit ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Disc Medicine Stock Is Swinging, but This Fund's New $52 Million Bet Shows Conviction ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kymera Stock Up 130% as $135 Million Buy Boosts Immunology Bet ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Kymera Therapeutics Stock Up 120% in 1 Year as Fund Adds $3 Million More ↗
    Via The Motley Fool
    News headline image
    Insider Buying: Smart Money Just Spent +$100M on These 3 Stocks ↗
    Via MarketBeat
    News headline image
    Streaming Wars Go Hostile Just as Wall Street Braces for the Fed ↗
    Via Chartmill
    Topics Economy
    News headline image
    What's going on in today's session ↗
    Via Chartmill
    News headline image
    There are notable gap-ups and gap-downs in today's session. ↗
    Via Chartmill
    News headline image
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    Why Is KYMR Stock Up 30% Pre-Market Today? ↗
    Via Stocktwits
    Topics Economy
    News headline image
    These stocks are moving in today's after hours session ↗
    Via Chartmill
    News headline image
    Kymera (KYMR) Q3 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    10 Analysts Have This To Say About Kymera Therapeutics ↗
    Via Benzinga
    News headline image
    Kymera Therapeutics Inc (NASDAQ:KYMR) Q3 2025 Earnings: Clinical Progress Overshadows Financial Miss ↗
    Via Chartmill
    News headline image
    The Analyst Verdict: Kymera Therapeutics In The Eyes Of 6 Experts ↗
    Via Benzinga
    News headline image
    Breaking Down Kymera Therapeutics: 4 Analysts Share Their Views ↗
    Via Benzinga

    Frequently Asked Questions

    Is Kymera Therapeutics, Inc. - Common Stock publicly traded?
    Yes, Kymera Therapeutics, Inc. - Common Stock is publicly traded.
    What exchange does Kymera Therapeutics, Inc. - Common Stock trade on?
    Kymera Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Kymera Therapeutics, Inc. - Common Stock?
    The ticker symbol for Kymera Therapeutics, Inc. - Common Stock is KYMR on the Nasdaq Stock Market
    What is the current price of Kymera Therapeutics, Inc. - Common Stock?
    The current price of Kymera Therapeutics, Inc. - Common Stock is 83.85
    When was Kymera Therapeutics, Inc. - Common Stock last traded?
    The last trade of Kymera Therapeutics, Inc. - Common Stock was at 04/28/26 04:00 PM ET
    What is the market capitalization of Kymera Therapeutics, Inc. - Common Stock?
    The market capitalization of Kymera Therapeutics, Inc. - Common Stock is 4.64B
    How many shares of Kymera Therapeutics, Inc. - Common Stock are outstanding?
    Kymera Therapeutics, Inc. - Common Stock has 5B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.